Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't thin financials matter this sector is based off further events and sales !! Imho
F the potatoes lol
im trying to figure if the financials are correct....
how they could afford a divy? yahoo financials might be off...or what? confused in the state of total anxiety, i dropped a handful of mash potatos
Does anyone know he share structure .... on the otc website just says not available for everything.... that can't be a positive thing
wow. that is good. ok, question
how many acres are needed to supply the whole nation? that is the land angle for sure. monopoly. cows, manure, fertilizer, land....
Mymmf is only mj company has a CITY as a partner getting 400 acres for free $$$$
No 85% owned by ivitf lol ..
Last quarter they made 789k cash
did i miss they own a herd of cows?
fertilizer company already making 85mm a year? bet that helps it grow in more ways than one. does it support the divy? that is what blew me away. a buck stock with a .39 divy. wowser. i checked out the mymmf and it seems really stuck on compliance angle vs. what we got here already pumping out and supplying an already medical sector that has to be tough to survive. but, it's less than half the price. hmmmmm gotta think on that IVITF will make you filthy stinking rich....unless there is something i dont know yet. you found the herd of manure that only helps. will it split and we end up with two business?????? in doing that with ecsl right now. happy days.
Agree 250 acres and 2 license could expand very big !!!
Also there 85% owned fertilizer company is doing millions in revenue
ill take a look. what winds my clock here
is that they have the land permits, etc. and can come out of the gatei n july and not run out of product. nevada just opened up and after a short time, they are short on product. planning ahead as ivitf has done, for the medical side insures the recreational side will have lots and lots. in my humble opinion
I like company honestly hoping for $5
Also mymmf looks really good !!!
cool. gotta load up first...but, it just blows my mind....divy on a penny stock? will that repeat? hope so. just gets better and better in my humble opinion.
2.50 or 250.? if i round up the loot...
tomorrow. lol. reads just too good, gotta research some more....where is the chink in their armor?
Yes sir I'll be here with you 2018 sounds great :) loaded and ready
that is the word* when i did my dd...
and found a dividend!!!! and they have the permits, licenses, land , and have been doing the medical side....ready for the big booom next july.
*wow
not a pump they got the goods and lead the pack in the great white
Where do think this is going ? $2.50 +
Why is ARCA here to ruin the party ...SMFH
The K2 Principal Fund L.P. announces updated position
http://www.marketwatch.com/story/the-k2-principal-fund-lp-announces-updated-position-in-invictus-md-strategies-corp-2017-07-19
TORONTO, Jul 19, 2017 (Canada NewsWire via COMTEX) -- The K2 Principal Fund L.P. ("K2") announces an updated holding in Invictus MD Strategies Corp. ("IMH") of 1108 - 1238 Seymour Street, Vancouver British Columbia V6B 6J3. Between May 31, 2017 and July 18, 2017 K2 had net sales of 1,629,750 shares with sale prices between $ 1.00 and $ 1.56 per share for total proceeds of $2,202,887.91. These sales were executed on the TSX Venture Exchange.
After the disposition stated above the K2 holds 8,794,850 common shares and 5,262,100 share purchase warrants for the purchase of an additional 5,262,100 common shares of IMH. Assuming the exercise of the warrants K2 would own a total of 14,056,950 common shares of IMH, representing approximately 16.47% of the issued and outstanding common shares of IMH on a partially diluted basis.
K2 disposed of the securities for investment purposes only and may, depending on market and other conditions, increase or decrease its beneficial ownership, control or direction over, or exercise its current rights to acquire, common shares or other securities of IMH through market transactions, private agreements or otherwise.
http://www.marketwatch.com/story/the-k2-principal-fund-lp-announces-updated-position-in-invictus-md-strategies-corp-2017-07-19
Agreed .. I don't think we've seen heavy volume for sector at all these are early birds ...
Ready hear updates I'm looking for $3 but if we expand bigger could see $6 + depends on sqft .....
We got plenty land .....
I bet we break 3mil in a single day sometime before the end of next month
Nice volume today so far
Hope it keeps up
Opportunity of the Decade for Canada's Cannabis Companies
http://www.prnewswire.com/news-releases/opportunity-of-the-decade-for-canadas-cannabis-companies-635381283.html
This little-known marijuana company is the only real entry point into the multi-billion-dollar Canadian pot market, and it's also the first marijuana company to pay a dividend to its shareholders. Active companies in the market include: Innovative Industrial Properties, Inc. (NYSE: IIPR), INSYS Therapeutics, Inc. (NASDAQ: INSY), GW Pharmaceuticals plc (NASDAQ: GWPH), OrganiGram Holdings Inc. (TSX-V: OGI.V), Emerald Health Therapeutics, Inc. (TSX-V: EMH.V)
Pot stocks were already skyrocketing-in some cases beyond 1700% - in anticipation that the Canadian government would put legislation on the table to legalize marijuana for recreational use in April. That's already happened, and now stocks are going wild because it should all be legal by July 1st, 2018. This is the making of a multi-billion-dollar market overnight. And this company could be the way in.
Meet Invictus MD (IMH.V; IVITF)-a small-cap that has redefined savvy in this sector and will be walking with the jolly green giants by this time next year-when high valuations will slam doors shut and only billionaires will emerge.
The Fast-track to Profits-The Lucrative Pot Pre-approval
In what will prove to be the biggest multi-decade opportunity for investors, Invictus has already won pre-approval by the Canadian health authority to produce 15 strains of marijuana. And this is only one of many firsts for this small-cap.
Right out of the gate, Invictus MD, owner of two of only 50 licenses, has demonstrated that it will lead the way. And it's cashed up and already generating dividends-a feat unheard of in the pot industry.
That's why it's called 'Canada's Cannabis Company' -it's already cemented market share for medical marijuana use, and now it's one of the first in and ready to fill the supply gap for a massive recreational push.
It's also the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and - most lucratively of all-recreation, the sky is the limit here.
Supply Deficit Looming-This is Bigger Than Beer
We're now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
The industry is scrambling to add greater capacity once these legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That's more than the combined sales of beer, wine and spirits.
We're going to be playing some serious catch-up, which is a producer's dream.
Legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year in Canada, according to Canaccord Genuity analysts. (And that's just for recreational use.)
Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.
Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021-up from nearly $7 billion last year. That's an annual growth rate of 26 percent, and it's in line with Deloitte's own estimations.
In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.
That's what happens when you end 'prohibition' for a market that is already huge-it's just hiding under the table. But this will blow away the billion-dollar industry that was reborn the moment alcohol prohibition ended on December 5, 1933.
Investors get it. That's why shares of medical marijuana producers more than tripled last year-just at the anticipation, and now that it is set to become legal, there is no telling what could happen.
• AXIM Biotechnologies: exploded 1,720 percent
• Corbus Pharmaceuticals was up 431 percent
• Aphria grew 381 percent
• Aurora Cannabis was up 299 percent
• Canopy Growth Corp. up 259 percent
• Medical Marijuana up 254 percent
• GW Pharmaceuticals was up 64 percent
In early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
Way Ahead of the Game, with a Massive Pot Pipeline
Invictus MD (IMH.V; IVITF) has multiple projects in its Canadian investment pipeline-all of them bolstered by some extremely savvy acquisitions. And they're not afraid of picks and shovels; they're all about hard work, if it's smart.
Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the 'picks and shovels' of the cannabis space. Invictus MD has made one smart move after another, and it's always the 'pick and shovel' guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it, less than a year before. That's how they managed their first shareholder dividend.
They've been targeting small- and mid-size companies with significant growth potential and direct their strategies towards profitability. And this business savvy gives them everything they need to produce cheaply and to corner this market-but still maintain a valuation far below their peers. That's why this is a very real entry point into this market for potential outsized gains.
The pipeline is impressive:
33% ownership in AB Laboratories Inc., which received its cultivation license in the third quarter of last year. A sales license is expected any day.
The AB facility has a capacity for 1,000 kilograms, with active expansion plans underway.
Invictus just closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.
In Alberta, Invictus owns 100% of Acreage Pharms, which has a license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot phase 2 expansion plan with capital to expand an additional 75,000 square feet.
So, what we're looking at here is a wildly undervalued company that has an amazing set of assets and a pipeline to produce which is poised to explode onto a recreational market that is already bursting at the seams.
They Actually Pay Dividends. Need We Say More?
No one expects pot producers to pay dividends-yet. Its still early days, even with medical marijuana. Even so, Invictus has already rewarded its shareholders, to everyone's surprise. It was a Christmas bonus no one expected, and it speaks volumes about this company and its management.
In the words of Invictus Chairman and CEO, Dan Kriznic, "It made sense to give back to those who supported us." Kriznic has been rated one of Business in Vancouver's 'Top 40 under 40', and he's put Invictus on the fast track to the market.
This CEO has turned $10-million companies into $150-million annual revenue generators. They've got a license to grow in more ways than one, and while they might not be a 'green giant' just yet, their undervaluation suggests they could be.
Why Invictus?
This company's not only rewarding shareholders early, but it's not afraid of hard work, and it has prime real estate for a cash crop that's going to keep growing.
The company has a funded production capacity of about 18,000 kilograms. Compared to its peers, this suggests significant undervaluation.
And not only are its strains pre-approved by the health authorities, but they will reach into every corner of the market. It's a marijuana octopus that has left no stone unturned.
Invictus MD's market cap to funded capacity is about 5 times the industry standard.
This is the only door to walk through to the land of marijuana profits, but it won't be open much longer.
http://www.prnewswire.com/news-releases/opportunity-of-the-decade-for-canadas-cannabis-companies-635381283.html
Invictus MD Completes First Harvest & Breaks Ground on Expansion
http://www.cannabisfn.com/invictus-md-completes-first-harvest-breaks-ground-expansion/
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte Canada, driven by the legalization of medical and recreational cannabis nationwide. While there are many opportunities for investors interested in the space, the best companies provide a high level of geographical and business diversification to maximize risk-adjusted returns over the long run.
In this article, we will look at Invictus MD Strategies Corp.’s (TSX-V: IMH) (OTC: IVITF) (FFT: 81S) progress in building out its presence in Canada’s licensed producer marketplace, as well as its successful ancillary businesses.
Initial AB Labs Harvest
Invictus MD Strategies’ 33% owned AB Labs is a 16,000-square foot purpose built concrete and steel facility in Hamilton, Ontario with 1,000 kilograms of annual production capacity. In addition to this approved capacity, the company is actively seeking adjoining properties for direct expansion into the existing facility. The facility is initially focused on strains that have varying levels of tetrahydrocannabinol (THC) and cannabidiol (CBD).
On July 13, the company announced that AB Labs completed its first harvest four weeks ago and anticipates a monthly harvest moving forward. These activities should begin generating significant revenue for the company moving into the second half of the year, which will scale up as the company increases production capacity over time. Management anticipates about 250 kilograms of production in 2017 before scaling up to 1,000 kilograms in future years.
Expansion Opportunities
Invictus MD Strategies has been making tremendous progress in advancing its other cannabis production facilities across Canada. With a $30 million capital outlay, the company plans to build out 147,550 square feet of production that’s capable of generating 16,850 kilograms per year of cannabis. The company’s share of the production from non-wholly-owned subsidiaries will be approximately 14,513 kilograms per year.
AB Ventures – a subsidiary formed to develop a second licensed expansion facility in Hamilton, Ontario – is forging ahead with planning its Phase I expansion. The initial fully-funded $5.5 million expansion will be a 21,000-square foot purpose built facility capable of producing 3,000 kilograms per year. Management plans on completing this initial phase by the end of the year with plans to build an additional 21,000 square foot building envelope.
Acreage Pharms received a development permit for Phase II and has broken ground for the 27,800-square foot purpose built, multiple room production facility. The contracts and supplies necessary to complete the project have been scheduled and the company is prepared to invest $6 million toward the cost of constructing the production facility. The Phase III expansion will be a 76,750-square foot facility capable of producing 9,210 kilograms per year.
Ancillary Businesses
Invictus MD Strategies differs from conventional licensed producers with its diversification into related equipment and nutrient businesses.
Future Harvest is an 82.5% owned manufacturer and distributor of hydroponic and indoor growing equipment. With over 20 years of history in the industry, the company provides more than 40 proprietary products that account for about 95% of what it sells. Management anticipates revenue to grow from C$2.5 million in 2017 to more than C$5 million by 2019 with C$750,000 in EBITDA, which will contribute meaningfully to its bottom line.
In the past, the company has generated significant returns from acquiring and selling these kinds of ancillary businesses. For example, the company acquired a 100% stake in Cannabis Health for $45,000 that it sold for $275,000 in just 10 months. Management also sold off the Sunblaster assets from Future Harvest for $3.75 million after acquiring a 75% stake in the company for just $900,000 just under a year ago.
Looking Ahead
Invictus MD Strategies Corp. (TSX-V: IMH) (OTC: IVITF) (FFT: 81S) represents a compelling opportunity within the Canadian cannabis industry. With a growing presence in the licensed producer space, the company is already generating revenue with approved facilities while targeting significant expansion opportunities ahead. The company also offers investors exposure to the equipment and nutrients side of the business via Future Harvest.
http://www.cannabisfn.com/invictus-md-completes-first-harvest-breaks-ground-expansion/
Huge buys coming in :) ..... $3 2018
This is going to be huge!
Good luck everyone $ivitf
The Best Kept Secret Of The Marijuana Boom
This little-known marijuana company is the only real entry point into the multi-billion-dollar Canadian pot market, and it's also the first marijuana company to pay a dividend to its shareholders.
Pot stocks were already skyrocketing—in some cases beyond 1700%--in anticipation that the Canadian government would put legislation on the table to legalize marijuana for recreational use in April.
That's already happened, and now stocks are going wild because it should all be legal by July 1st, 2018. This is the making of a multi-billion-dollar market overnight.
And this company could be the way in ...
Meet Invictus MD (TSX:IMH.V; OTC:IVITF)—a small-cap that has redefined savvy in this sector and will be walking with the jolly green giants by this time next year—when high valuations will slam doors shut and only billionaires will emerge.
The Fast-Track to Profits—The Lucrative Pot Pre-Approval
In what will prove to be the biggest multi-decade opportunity for investors, Invictus has already won pre-approval by the Canadian health authority to produce 15 strains of marijuana.
And this is only one of many firsts for this small-cap.
Right out of the gate, Invictus MD, owner of two of only 50 licenses, has demonstrated that it will lead the way. And it's cashed up and already generating dividends—a feat unheard of in the pot industry.
That's why it's called 'Canada's Cannabis Company'—it's already cemented market share for medical marijuana use, and now it's one of the first in and ready to fill the supply gap for a massive recreational push.
It's also the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.
Supply Deficit Looming—This is Bigger Than Beer
We're now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
The industry is scrambling to add greater capacity once these legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That's more than the combined sales of beer, wine and spirits.
We're going to be playing some serious catch-up, which is a producer's dream.
- Legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year in Canada, according to Canaccord Genuity analysts. (And that's just for recreational use.)
- Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.
- Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021—up from nearly $7 billion last year. That's an annual growth rate of 26 percent, and it's in line with Deloitte's own estimations.
- In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.
That's what happens when you end 'prohibition' for a market that is already huge—it's just hiding under the table. But this will blow away the billion-dollar industry that was reborn the moment alcohol prohibition ended on December 5, 1933.
Investors get it. That's why shares of medical marijuana producers more than tripled last year—just at the anticipation, and now that it is set to become legal, there is no telling what could happen.
- AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
- Corbus Pharmaceuticals (NASDAQ:CRBP) was up 431 percent
- Aphria (NASDAQOTH:APHQF) grew 381 percent
- Aurora Cannabis (NASDAQOTH:ACBFF) was up 299 percent
- Canopy Growth Corp. (NASDAQOTH:TWMJF) up 259 percent
- Medical Marijuana (NASDAQOTH:MJNA) up 254 percent
- GW Pharmaceuticals (NASDAQ:GWPH) was up 64 percent
In early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
Way Ahead of the Game, with a Massive Pot Pipeline
Invictus MD (TSX:IMH.V; OTC:IVITF) has multiple projects in its Canadian investment pipeline—all of them bolstered by some extremely savvy acquisitions. And they're not afraid of picks and shovels; they're all about hard work, if it's smart.
Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the 'picks and shovels' of the cannabis space. Invictus MD has made one smart move after another, and it's always the 'pick and shovel' guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before. That's how they managed their first shareholder dividend.
They've been targeting small- and mid-size companies with significant growth potential and direct their strategies towards profitability. And this business savvy gives them everything they need to produce cheaply and to corner this market—but still maintain a valuation far below their peers. That why this is a very real entry point into this market for potential outsized gains.
The pipeline is impressive:
- 33% ownership in AB Laboratories Inc., which received its cultivation license in the third quarter of last year. A sales license is expected any day.
- The AB facility has a capacity for 1,000 kilograms, with active expansion plans underway.
- Invictus just closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.
- In Alberta, Invictus owns 100% of Acreage Pharms, which has a license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot phase 2 expansion plan with capital to expand an additional 75,000 square feet..
So, what we're looking at here is a wildly undervalued company that has an amazing set of assets and a pipeline to produce which is poised to explode onto a recreational market that is already bursting at the seams.
They Actually Pay Dividends. Need We Say More?
No one expects pot producers to pay dividends—yet. It's still early days, even with medical marijuana. Even so, Invictus has already rewarded its shareholders, to everyone's surprise. It was a Christmas bonus no one expected, and its speaks volumes about this company and its management.
In the words of Invictus Chairman and CEO, Dan Kriznic, "It made sense to give back to those who supported us."
Kriznic has been rated one of Business in Vancouver's 'Top 40 under 40', and he's put Invictus on the fast track to the market.
This CEO has turned $10-million companies into $150-million annual revenue generators. They've got a license to grow in more ways than one, and while they might not be a 'green giant' just yet, their undervaluation suggests they could be.
Why Invictus?
This company's not only rewarding shareholders early, but it's not afraid of hard work, and it has prime real estate for a cash crop that's going to keep growing.
- The company has a funded production capacity of about 18,000 kilograms. Compared to its peers, this suggests significant undervaluation.
- And not only are its strains pre-approved by the health authorities, but they will reach into every corner of the market. It's a marijuana octopus that has left no stone unturned.
- Invictus MD's market cap to funded capacity is about 5 times the industry standard.
This is the only door to walk through to the land of marijuana profits, but it won't be open much longer.
You can find out more on Invictus MD at the following links (TSX:IMH.V; OTC:IVITF)
More companies to watch:
Ag Growth International Inc (TSE:AFN): The agricultural industry is sure to take advantage of the legal cannabis boom in Canada, and AG Growth International is as good a place as any to find value. With a nice dividend and a strong first half of 2017.
CanniMed Therapeutics Inc (TSE:CMED): This Canada-based plant biopharmaceutical company was the first licensed marijuana producer to sign a deal with a national pharmacy chain. With its stock trading at nearly a 52-week low, there is certainly value to be found in this company when the new Marijuana legislation kicks in.
Theratechnologies Inc (TSE:TH): Possibly the best performing pharmaceutical stock of 2017, Theratechnologies has seen its stock soar nearly 300 percent since January 1st. It will remain a stock to watch in drug markets, and if its current growth trend continues investors will be seeing some incredible returns.
ProMetic Life Sciences Inc. (TSX:PLI)—This $1.2 billion-market cap company has remedied its financing overhang, and also got a boost from a $9.5-million purchase order this year. While it has had a rough year to date, the price target remains positive – with several analysts believing it is currently oversold.
Aurora Cannabis Inc. (TSXV:ACB)—another Canadian cannabis giant-in-the-making, this company could challenge Canopy Growth. There is really no going wrong in the Canadian cannabis market over the next year, with reputable companies sure to gain a decent market share.
Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of Baystreet.ca only and are subject to change without notice. Baystreet.ca assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.
Exciting times indeed
Wait Until they announce why they have all that land :)
agreed.
this stock is going to be huge.
it is one of my top stocks.
Agreed here, loading at these levels should yield significant ROI. Especially since it's trading on the TSX (Canadian Nasdaq) - almost 0 manipulation like the OTC!
this is awesome.
great post.
She's moving! Let's close HOD folks!
80k on bid at $1
Looking good here folks! Test $1.10? This is the next massive weed play, only 60 mill float!
Going to be a good 2018 GLTU
Looks like it's running to that level Sir Camelot. Have you seen the new article published yesterday? $30 mill cash on hand, 60 mill float, 2 of the 50 licenses available in Canada. Loading at these levels is a no brainer.
With one of the largest land packages to build cultivation facilities and 2 current licensed facilities located in two provinces in Canada, small-cap Invictus MD (IMH.V; IVITF) is set to rise.
It's already the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and - most lucratively of all-recreation, the sky is the limit here.
We're now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
Financial Post reports... there will soon be 3.8 million recreational users... But the market is only currently equipped to handle 150,000 medical marijuana patients.
The industry is scrambling to add growing capacity once the legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That's more than the combined sales of beer, wine and spirits.
Right out of the gate, Invictus MD, owner of two of just 50 licenses, has demonstrated that it will lead the way. The company holds $30 million in cash and is already generating dividends-a feat unheard of in the pot industry.
That's why it's called 'Canada's Cannabis Company'-it's already cemented market share for medical marijuana use, and now it's one of the first in and ready to fill the supply gap for a massive recreational push to supply 3.65 million new users.
Here are 5 Reasons to keep a close eye on Invictus MD (IMH.V; IVITF):
# 1 The Minting of the Next North American Billionaires
When you suddenly legalize a product that's already got a massive market under the table, you mint billionaires overnight. Just like it did at five o'clock on December 5, 1933-the moment Prohibition ended, and a billion-dollar industry (even then) was reborn.
It's already happening: The shares of the medical marijuana producers more than tripled last year, just at the prospects.
• AXIM Biotechnologies: exploded 1,720 percent
• Corbus Pharmaceuticals was up 431 percent
• Aphria grew 381 percent
• Aurora Cannabis was up 299 percent
• Canopy Growth Corp. up 259 percent
• Medical Marijuana up 254 percent
• GW Pharmaceuticals was up 64 percent
The smart money is investing too. Tribeca Investment Partners, a boutique fund manager, used bets on marijuana companies to help generate a 145 percent return over the year, according to Fortune magazine and Bloomberg. Nearly US$20 million of its investment gains in 2016 came from marijuana stocks, including Aurora Cannabis and Canopy Growth.
Then, in early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
The frenzy surrounding Canada's marijuana market is palpable, and will be even more frenzied on 1 July 2018.
And Invictus is way ahead of this game: It's already got a license to produce in this multi-billion-dollar market.
#2 A Pot Pipeline Going in Every Direction
Invictus MD (IMH.V; IVITF) has multiple projects in its Canadian investment pipeline-all of them bolstered by some extremely savvy acquisitions.
The company's dream team targets small- and mid-size companies with significant growth potential and directs their strategies towards profitability.
They've made some game-changing acquisitions at just the right time; yet, their valuation is far below their peers, making Invictus a real entry point into this lucrative market if you're looking for outsized gains.
The company owns over 33 percent of AB Laboratories Inc., which received its cultivation license last October. The catalysts here are mounting, with the sales license expected in Q2. This facility has a capacity for 1,000 kilograms, with active expansion plans underway.
In May, Invictus also closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.
In Alberta, Acreage Pharms received its license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot expansion plan. Invictus MD currently owns 100 percent of this license.
It's a brilliant set-up for a small-cap company with CAD$30 million in cash and 78 million basic outstanding shares.
#3 Pot Dividends? The Impossible Because Reality
Invictus MD (IMH.V; IVITF)-made history in December by giving shareholders something they never expected to see in the marijuana industry in this decade: dividends.
The logic of Chairman and founder Dan Kriznic is one that shareholders will certainly appreciate: "It made sense to give back [to those] who supported us."
Not only have shareholders gotten dividends in an industry that generally hasn't been mature enough to pay out-yet-but there's a reason this company is a uniquely attractive entry point: Invictus MD's market cap to funded capacity is about 5 times the industry standard.
Right now, the company has a funded production capacity of about 18,000 kilograms which, compared to its peers, suggests Invictus MD is significantly undervalued.
Its smart acquisitions have made all the difference.
Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the 'picks and shovels' of the cannabis space. Invictus MD has made one smart move after another, and it's always the 'pick and shovel' guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before.
They've been nurturing their shareholders along with their crops. Invictus MD's focus on two verticals-cannabis cultivation and cannabis fertilizer and nutrients-gives it a competitive, low-cost advantage on this playing field.
Now they've got prime real estate to add to their portfolio, and this is one cash crop that should keep growing.
#4 ' Top 40 under 40 ' in Vancouver
There's a reason this company is positioned for great things. Kriznic has been rated one of Business in Vancouver's 'Top 40 under 40', and he's put Invictus on the fast track to the market. He has built over a billion dollars in value for shareholders in his past.
And not only are the strains pre-approved by the health authorities, but they will reach into every corner of this market. It's a marijuana octopus that has left no stone unturned.
Those strains include high THC strains used to help with pain management and cancer, and high-CBD strains used for epilepsy and anxiety disorders. And when it comes to recreational-the company is gearing up to work on all strains available.
This combined with its tight capitalization structure and access to capital could make this a prime breakout target over the coming weeks and months.
They're also not new to this game. Invictus MD isn't just jumping on the green train at the 11th hour; it has been laying the ground work for a very smart expansion strategy.
Kriznic has turned $10-million companies into $150-million annual revenue generators. They've got a license to grow in more ways than one, and while they might not be a 'green giant' just yet, their undervaluation suggests they could be.
#5 Massive Demand Just Waiting to Be Legalized
The fundamentals are clear-demand is set to further explode once recreational use of cannabis becomes legal.
Where does this leave us with supply? Playing some serious catch-up, which is a producer's dream. In Canada, legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year, according to Canaccord Genuity analysts. And that's just for recreational use. Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.
Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021-up from nearly $7 billion last year. That's an annual growth rate of 26 percent, and it's in line with Deloitte's own estimations.
In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.
If you haven't considered an entry point into this market yet-the window of opportunity is closing fast. Stocks are already shooting up on anticipation, and by 1 July 2018, high valuations will slam doors shut and only billionaires will come out. By that time, Invictus MD (IMH.V; IVITF) should already be walking with the green giants
Read more at www.stockhouse.com/news/press-releases/2017/07/17/billionaires-bet-big-on-canada-s-newest-22-billion-market#D2sjmC7LZ77IitmK.99
News yesterday showing how undervalued Invictus is and how they should be treading 2x higher, minimum!
http://www.stockhouse.com/news/press-releases/2017/07/17/billionaires-bet-big-on-canada-s-newest-22-billion-market
Still a good time to load at this level folks!
Agreed , also biggest land package I waiting on them to say there building a huge green house ? Could happen ?
Wouldn't be surprised to see close to 2$ by eoy
This one is still far under the radar
Solid management imo
Looks like a GAPPER :) let's goooooo
Hey Pete easymoney from here !!
$IVITF Invictus MD's Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update
Source: InvestorsHub NewsWire
VANCOUVER, BC - JULY 14, 2017 - InvestorsHub Newswire - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Acreage Pharms Ltd. (“Acreage Pharms”) located near Edson, Alberta, utilizing a multi-room indoor perpetual growing methodology, will begin its first harvest the first week of August, with the second harvest occurring the following week. The company anticipates a harvest to take place approximately monthly going forward.
Invictus MD is further pleased to announce that Acreage Pharms has received its development permit for Phase 2 and has broken ground initiating construction on its 27,800 square foot purpose built, multiple room production facility. All contractors and suppliers necessary for the project have been scheduled. Invictus MD has committed to investing $6.0 million, which will be used to fund the costs of constructing the production facility.
"Following our successful harvest at the AB Laboratories production facility as announced earlier, and by securing the development permit for our Alberta production facility, with $30 million cash available and the majority earmarked for building production capacity, Invictus MD is prepared for an exciting year of growth,” said Dan Kriznic, Executive Chairman and CEO, Invictus MD. “Led by one of the industry's most experienced teams, we are strongly focused on building our shareholder value. With 250 acres of cultivation space that stretches from Alberta to Ontario, allowing for purpose built production facilities rather than retrofitting existing buildings, our large land package allows for building cultivation facilities as demand increases and we will continue the disciplined but agile execution of our business strategy, and further establishing our leadership position as Canada’s cannabis company” added Kriznic.
Invictus MD also announced that Mr Paul Sparkes and Mr. Josef W. Hocher have been appointed to the Company’s Board of Directors.
Mr. Paul Sparkes is an accomplished business leader with over twenty five years' experience in media, public affairs, venture capital, and Canada's political arena. He is Currently President of Otterbury Holdings Inc., a corporation advising growth companies in the private and public markets. Most recently Mr. Sparkes was Executive Vice Chair, Director and co-founder of Difference Capital Financial, a TSX-listed specialty finance company. Previously, Mr. Sparkes was Executive Vice President, Corporate Affairs for CTVglobemedia (now Bellmedia). Prior to joining Bell Globemedia in 2001 as Group Vice-President, Public Affairs, Mr. Sparkes held senior positions in public service, including with the Government of Canada and the Government of Newfoundland and Labrador. From 1996 to 2001, he served in the Office of the Prime Minister of Canada as Director of Operations, and Special Assistant for Atlantic Canada. Mr. Sparkes also served as Executive Assistant to two Premiers of Newfoundland and Labrador. Mr. Sparkes sits on several public and private boards including Thunderbird Entertainment (private), Bluedrop Performance Learning Inc. (TSXV: BPL), Antler Gold Inc ( TSXV:ANTL.V) BlastGard International Inc (BLGA-US) and is a former board member of the Liquor Control Board of Ontario ( LCBO).
Mr. Josef W. Hocher was a founder of Buried Hill Energy, an international oil and gas company, where he acted as co-chief executive in creating, developing and implementing the organization’s strategic direction. He continues to serve as the Senior Independent Director and is also either a Chair or a member of various committees. Mr. Hocher also founded Hitic Energy Ltd., and was a partner at Osler, Hoskin & Harcourt LLP. He currently serves as Chairman of Orthoshop Geomatics Ltd., a geomatics services company; holds the position of Chief Commercial Officer at Field Upgrading Limited and Western Hydrogen Limited and since 2016, has been a Partner at Cassels, Brock & Blackwell LLP.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR, including its wholly owned subsidiary Acreage Pharms Ltd., as well as its investment in the fully licensed facility AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Executive Chairman & CEO
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
Cautionary Note Regarding Forward-Looking Statements: Statements contained in this news release that are not historical facts are "forward-looking information" or "forward-looking statements" (collectively, "Forward-Looking Information") within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward Looking Information includes, but is not limited to, disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; and the plans for completion of the Offering, expected use of proceeds and business objectives. In certain cases, Forward-Looking Information can be identified by the use of words and phrases such as "anticipates", "expects", "understanding", "has agreed to" or variations of such words and phrases or statements that certain actions, events or results "would", "occur" or "be achieved". Although Invictus has attempted to identify important factors that could affect Invictus and may cause actual actions, events or results to differ materially from those described in Forward-Looking Information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended, including, without limitation, the risks and uncertainties related to the Offering not being completed in the event that the conditions precedent thereto are not satisfied. In making the forward-looking statements in this news release, Invictus has applied several material assumptions, including the assumptions that (1) the conditions precedent to completion of the Offering will be fulfilled so as to permit the Offering to be completed on or about June 1, 2017; (2) all necessary approvals will be obtained in a timely manner and on acceptable terms; and (3) general business and economic conditions will not change in a materially adverse manner. There can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Information. Except as required by law, Invictus does not assume any obligation to release publicly any revisions to Forward-Looking Information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Invictus MD provides corporate update on Acreage Pharms -----> https://technical420.com/cannabis-article/invictus-md-provides-update-acreage-pharms
Followers
|
102
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7743
|
Created
|
02/08/17
|
Type
|
Free
|
Moderators |
The companies we seek to invest in demonstrate certain traits, which we believe are attractive to the creation of long-term shareholder value. Those traits include:
We work in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.
Invictus MD’s primary objective is to identify, grow and build companies that are complementary to one another. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries.
We recognize the key to success is in our people. Our strong management team has built and managed successful operations with enterprise values over $500 million in various industries. We believe each of our team members bring a unique skill set that helps drive the growth of our portfolio companies.
The benefit that results when we work together with our portfolio companies is much greater than when our portfolio companies work alone. Our investment philosophy requires all investments to be synergistic in order to allow for effective and efficient growth plans. This creates economies of scale and builds competencies that are core to our operating activities.
We recognize the importance of seeking leading edge companies that operate in emerging industries in order to build our global community. Our extensive business network allows for us to identify and executive on these opportunities.
Our core focus is to identify and invest in companies operating in emerging markets. We recognize that through technological advancements the world is getting smaller and various opportunities exist to assist and enter into these new markets.
Our team works closely with the management of the portfolio companies on a daily basis to help support them in all areas of their business including operations, financial reporting, information technology, human resources and marketing.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |